Top compounds associated with response to ANKRD17


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.15 1e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA CP466722 GDSC1000 pan-cancer AAC 0.15 1e-06
mRNA OSI-930 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA RG-108 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.15 3e-06
Download CSV